EBITDA Margin: Earnings before interest, taxes, depreciation and amortization as a portion of total revenue. Calculated as: EBITDA / Total Revenues
Akero Therapeutics, Inc. (AKRO) EBITDA Margin data is not available.
| Income Statement Financials | |
-- |
|
$-81.57M |
|
-- |
|
-- |
|
$90.24M |
|
$-90.24M |
|
$8.67M |
|
$-81.57M |
|
$-81.57M |
|
$-81.57M |
|
$-81.57M |
|
$-81.57M |
|
$-81.57M |
|
$-90.24M |
|
$-92.49M |
|
82.01M |
|
82.01M |
|
$-0.99 |
|
$-0.99 |
|
| Balance Sheet Financials | |
$754.53M |
|
-- |
|
$251.04M |
|
$1.01B |
|
$47.65M |
|
-- |
|
$0.29M |
|
$47.94M |
|
$957.64M |
|
$957.64M |
|
$957.64M |
|
80.15M |
|
| Cash Flow Statement Financials | |
$-183.08M |
|
$-346.06M |
|
$364.94M |
|
$340.24M |
|
$176.03M |
|
$-164.21M |
|
$27.10M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
15.83 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
|
EBITDA Margin |
-- |
-- |
|
-- |
|
$-183.08M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-8.52% |
|
-8.52% |
|
-8.11% |
|
-8.52% |
|
$11.95 |
|
$-2.23 |
|
$-2.23 |
|